Darbepoetin alfa biosimilar - JCR Pharmaceuticals/Kissei Pharmaceutical
Alternative Names: JR-131Latest Information Update: 30 Oct 2021
At a glance
- Originator JCR Pharmaceuticals; Kissei Pharmaceutical
- Class Antianaemics; Recombinant erythropoietins
- Mechanism of Action Erythropoiesis stimulants; Erythropoietin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Anaemia